Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Phase III (Hormonal Therapy) Phase III (Hormonal Therapy)
Phase III (Hormonal Therapy) and Phase I (Hormonal Therapy) and
Upcoming
Integrated Cardiology PACS Integrated Cardiology PACS
Integrated Cardiology PACS contributes a major share in the total Cardiology PACs market. This can be further segmented on the basis of Geographies, Components, Deployments, Applications, Companies, MacroIndicators and Endusers. Deep dive analysis of the key players of this domain have been considered in this report.  
Upcoming
Standalone Cardiology PACS Standalone Cardiology PACS
Standalone Cardiology PACS has gained much imporatnce in its immediated parent market, named Cardiology PACS market. Depending on different Geographies, Components, Deployments, Applications, Companies, MacroIndicators and Endusers, this market has been segmented in this report. Deep dive analysis of the key players of this domain, have also been presented.
Upcoming
Integrated Radiology PACS Integrated Radiology PACS
Integrated Radiology PACS has been considered as a major contributor of the Radiology PACS market.  Segmentation of this market, based on Geographies, Components, Deployments, Applications, Companies, MacroIndicators and Endusers, is the prime concern of this report. In addition to that, deep dive analysis of the key players of this domain, have also been considered.
Upcoming
Standalone Radiology PACS Standalone Radiology PACS
Standalone Radiology PACS is often considered to be an important part of the total  Radiology PACS market. It can be segmented by Geographies, Components, Deployments, Applications, Companies, MacroIndicators and Endusers. Deep dive analysis of the top players of this domain, have ben enclosed in this report.
Upcoming
Asia-Pacific Cardiac Output Monitoring Devices Asia-Pacific Cardiac Output Monitoring Devices
Asia-Pacific market is expected to grow at a very fast rate. More and more key players are shifting their focus towards Asia-Pacific due to saturation of North American and European markets.The Cardiac Output Monitoring Devices Market can be segmented by Geographies, Product type, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players of this market have been considered in the report.
Upcoming
Electrical Ablation Electrical Ablation
The Global Electrical Ablation Market was pegged at $867 million in 2013 and expected to be $1098 million by 2018. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland).
Upcoming
Hydrothermal Ablation Hydrothermal Ablation
The Global Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery. An endometrial hydrothermal balloon ablation device is the major technology indulged in hydrothermal ablation market. The main companies operating in hydrothermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
Asian Sleep Apnea Devices Asian Sleep Apnea Devices
The Sleep Apnea Devices market in Asia has been slated to gather pace in the coming years as a result of the awareness levels of Sleep Apnea. The market is clinched at $1.4 billion in 2013 and is expected to reach a value of $3.1 billion in 2018, with a CAGR of 17.5% from 2013-2018. The market has been segmented on the basis of Products, Geographies (Japan, China, India), Endusers, Companies and Macroindicator. The main companies operating in the market are Philips Respironics, ResMed, Inc., Fisher & Paykel Healthcare, Carefusion, Corp., DeVilbiss Healthcare, Weinmann Medical Devices, BMC Medical Co. Ltd., Natus Medical, Inc., Compumedics, Ltd., Nihon Kohden Corporation and other companies. Deep dive analysis of the key players have been considered in this report.
Upcoming
Light/Laser Ablation Light/Laser Ablation
The Global Light/Laser Ablation Market,  was pegged at $1183 million in 2013 and expected to be $1859 million by 2018. The light/laser ablation devices consist of two types of lasers namely, cold lasers and excimer lasers. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others.
Upcoming
Asia Dental Implants Asia Dental Implants
Asia forms one of the most promising dental implants markets in the world.Asian Dental implants market can be segmented by Geographies,Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
Europe Dental Implants Europe Dental Implants
Europe is the region of origin of implant dentistry; therefore, the penetration rate of dental implants is very high in this region. European Dental Prosthetics can be segmented by Geographies,Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
North America Dental Implants North America Dental Implants
The North American Dental Implants Market, mainly driven by aging population and insurance coverage for dental procedures. North American Dental Implants Market can be segmented by Geographies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
Radiation Ablation Radiation Ablation
The Global Radiation Ablation Market was pegged at $3735 million in 2013 and expected to be $5537 million by 2018. In terms of volume, the stereotactic radiotherapy and radiosurgery devices accounted for the largest volume in sales.The main companies operating in this market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Asia Dental Prosthetics Asia Dental Prosthetics
Prosthetic dentistry is the dental forte relating to the analysis, treatment, recovery and support of the oral function, with the use of dental crowns & bridges, dentures, and abutments.Asian Dental Prosthetics can be segmented by Geographies,Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
Europe Dental Prosthetics Europe Dental Prosthetics
Prosthetic dentistry is the dental forte relating to the analysis, treatment, recovery and support of the oral function, with the use of dental crowns & bridges, dentures, and abutments.European Dental Prosthetics can be segmented by Geographies,Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
North America Dental Prosthetics North America Dental Prosthetics
-North American Dental Prosthetics market  can be segmented by Geographies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
Respiratory Devices Respiratory Devices
The global respiratory devices market has gained tremendous importance owing to the widspread acceptance of home healthcare devices. The market is clinched at $7.2 billion in 2013 and is expected to reach a value of $12.2 billion in 2018, with a CAGR of 11.0% from 2013-2018. The market has been segmented on the basis of products, geographies, end users, companies, and macro indicators. A deep-dive analysis of the key players has been considered in this report.
Upcoming
Radiofrequency Ablation Radiofrequency Ablation
The Global Radiofrequency Ablation Market was pegged at $1918 million in 2013 and expected to be $3854 million by 2018. This report also provides an extensive competitive landscaping of companies operating in radiofrequency ablation market. The key players in radiofrequency ablation market are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.).
Upcoming
North American Interventional Cardiology Devices North American Interventional Cardiology Devices
The North American Interventional Cardiology Devices Market, is expected to reach $8.35 billion by 2018 from $5.24 billion in 2013, growing at a CAGR of 9.8%.The North American Interventional Cardiology Devices Market can be segmented by Geographies, Products, Endusers, Companies and MacroIndicators. Deep dive analysis of the top players  of this market have been considered in this report.
Upcoming
2987 reports | Show
Connect With Us
US/CAN : +1-888-502-0539